Share Email Print
cover

Proceedings Paper • new

Development of a physical anthropomorphic breast phantom for objective task-based assessment of dedicated breast CT systems
Author(s): Jesse Salad; Lynda C. Ikejimba; Andrey Makeev; Christian G. Graff; Bahaa Ghammraoui; Stephen J. Glick
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

In this work we present a new methodology for creating a physical anthropomorphic breast phantom for use in dedicated breast CT (bCT) systems. We also present a method for modeling microcalcifications (MCs) in the phantom. An uncompressed digital breast was first created though analytical modeling. This virtual model is then physically realized through inkjet printing using doped ink and paper with radiographic properties similar to that of glandular and adipose tissues. In addition, MC cluster inserts were created using calcium hydroxyapatite (HA) spheres that ranged in diameter from 212-250um to 250-300um and could be inserted inside the phantom. The phantom was then assessed in terms of material realism and reproducibility using x-ray spectroscopy, a clinical full field digital mammography (FFDM) system, and a benchtop CT system. Results show that both the paper and ink used to create the physical phantom have radiographic properties which closely match reference values for glandular and adipose tissue. Further, reproducibility was confirmed through multiple prints. The phantom and MC inserts can be used to objectively assess image quality of dedicated bCT systems.

Paper Details

Date Published: 6 July 2018
PDF: 8 pages
Proc. SPIE 10718, 14th International Workshop on Breast Imaging (IWBI 2018), 107180S (6 July 2018); doi: 10.1117/12.2318524
Show Author Affiliations
Jesse Salad, U.S. Food and Drug Administration (United States)
Lynda C. Ikejimba, U.S. Food and Drug Administration (United States)
Andrey Makeev, U.S. Food and Drug Administration (United States)
Christian G. Graff, U.S. Food and Drug Administration (United States)
Bahaa Ghammraoui, U.S. Food and Drug Administration (United States)
Stephen J. Glick, U.S. Food and Drug Administration (United States)


Published in SPIE Proceedings Vol. 10718:
14th International Workshop on Breast Imaging (IWBI 2018)
Elizabeth A. Krupinski, Editor(s)

© SPIE. Terms of Use
Back to Top